LatticePoint Experience
Therapeutic and Global Experience
LatticePoint has been working with clients and major industry players for decades ranging from rare diseases, medical devices and a range of therapeutic areas. Our clients trust our world-class team of market access leader’s experience in the sciences, industry, venture capital and negotiations assess your product in the marketplace.
We have helped companies of all sizes and situations
-
Big Pharma
-
Emerging biopharma
-
Investors
-
BD/In-licensing teams
A range of therapeutic areas
Rare Diseases and/or Orphan Designation:
Oncology
- Relapse/refractory neuroblastoma
- Acute lymphoblastic/myeloid leukemia
Hematology
- Haemophilia-A and –B
- Beta-thalassemia (gene therapy)
- Hereditary Angioedema
Autoimmune diseases
- Idiopathic thrombocytopenic purpura (ITP)
- Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID – gene therapy)
Endocrinology
- Primary hyperparathyroidism
- Hypoparathyroidism
Others
- Cystic fibrosis
- Homozygous familial hypercholesterolaemia (oral, biologic)
- Severe veno-occlusive disease
- Duchenne Muscular Dystrophy (3-products)
- Lysomsomal Storage Disorders (Gaucher, Fabry – biologic, oral)
- Pompe Disease (biologic)
- Hunner’s lesions (interstitial cystitis)
- Calciphylaxis
Non-orphan Therapeutic Areas
Medicines
- Alzeimer’s disease
- Parkinson’s disease
- Multiple sclerosis
- Psoriasis (oral, biologic)
- Rheumatoid arthritis (biologic)
- Oncology, including bladder, pancreatic, breast, ovarian, neuroblastoma
- Hereditary ATTR amyloidosis (biologic)
- wet-AMD, Retinal Vein Occlusion, Diabetic Macular Edema
- Acute, chronic Pain / Uremic Pruritus
- Systemic Lupus Erythematosus
- Bronchiolitis Obliterans
- Stroke Prevention/Thrombosis
- Pain (Neuropathic, osteoarthritis, opioid, NGFi)
- Antibiotics
- Hepatitis C
Medical devices/Non-drug intervention
- Endomicroscopy system
- Wound care dressings
- Laser Cataract Surgery
- Fertility products
- Nutrition products
Global negotiation experience
At LatticePoint, we have in-country experience working with, and on behalf of, our clients who require on-the-ground assistance. Our multilingual staff of native German, French, Italian, Spanish and English speakers is experienced at handling negotiations in many key countries while keeping an eye on cross-border implications. We engage with payers, providers, HTA bodies and EMA for early access, give feedback on clinical program design, and conduct in-country reimbursement negotiations in key markets around the world. We also retain a Global Payer Panel for market research.
